Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PSORS1C3 (Psoriasis susceptibility 1 candidate 3) is a human long non-coding RNA (lncRNA) gene located in the major histocompatibility complex (MHC) region and transcribed in several splice variants[1][2][4]. It is adjacent to, and partially overlaps with, the OCT4 (POU5F1) gene, a key transcription factor in stemness, proliferation, and the stress response[1][2]. PSORS1C3’s genomic elements act as enhancers or fine-tuners of OCT4 expression, particularly in non-pluripotent cells, and its transcription is sensitive to glucocorticoids through glucocorticoid receptor (GR/NR3C1) binding at its promoters[1][2]. Genetic association and functional studies suggest roles for PSORS1C3 in the pathogenesis of psoriasis and other immune-mediated diseases, likely by modulating the immune response and local chromatin structure[1][2][4]. No direct protein products or canonical receptor/target characteristics are reported, and it is not targeted by current therapeutics or known to serve as a biomarker outside research contexts[1][2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Psoriasis susceptibility 1 candidate 3 (PSORS1C3).